510(k) Report

510(k) · Cleared

Recalled · Class II · 2022

Heparin Lock / Flush Syringes

K133446510(k) TraditionalCleared Nov 14, 2014367-day reviewClass II21 CFR 880.5200Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Excelsior Medical Corporation · NZW Heparin, Vascular Access Flush

Cleared on Nov 14, 2014 as substantially equivalent to K023740 (Excelsior Medical Corp., 2003) and 1 other predicate after a 367-day review. Its family tree reaches back 1 generation to 2003. It has been recalled once.

Decided
Nov 14, 2014
Review
367 days
Class
Class II
Product code
NZW
Recalls
1
Predicates
2

Its longest line of descent runs back 1 generation to K023740 (2003). 2 ancestors in all. No later device cites it as a predicate yet.

Other ancestors, by year cleared 2007: 1 other ancestorK023740 · Syrex Pre-Filled Syringe · Excelsior Medical Corp. · 2003 · recalled2000200520102015
Other ancestors, by generation 1 generation back: 1 other ancestor K023740 · Syrex Pre-Filled Syringe · Excelsior Medical Corp. · 2003 · recalled0
  1. Root · 1 generation backK023740 Syrex Pre-Filled SyringeExcelsior Medical Corp. · 2003 · Recalled
  2. This deviceK133446 Heparin Lock / Flush SyringesExcelsior Medical Corporation · 2014
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K023740Syrex Pre-Filled SyringeExcelsior Medical Corp.20031
0 (this device)K133446Heparin Lock / Flush SyringesExcelsior Medical Corporation2014—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200710
FIG. 1 — Lineage of K133446, 2003–2014Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in NZW? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K023740Syrex Pre-Filled Syringe
Summary page 4
…g devices as related to intended use, design, and material characteristics:  Syrex Pre-Filled Syringe, 10 U/mL & 100 U/mL, Excelsior Medical Corporation, K023740  Syrex Heparin Lock Flush Syringe, 1 U/mL & 2 U/mL, Excelsior Medical Corporation, K061497 Description of the Dev…
Excelsior Medical Corp.20031
*K061497Syrex Heparin Lock Flush Syringe, 1 Unit/ML & 2 Units/ML
Summary page 4
…nge, 10 U/mL & 100 U/mL, Excelsior Medical Corporation, K023740  Syrex Heparin Lock Flush Syringe, 1 U/mL & 2 U/mL, Excelsior Medical Corporation, K061497 Description of the Device Excelsior Medical’s Heparin Lock Flush, USP devices are provided as terminally sterilized, single-use…
Excelsior Medical Corp.200713

Also cleared against K023740: 2 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
May 25, 2022Class IIZ-1596-2022Environmental controlFacility Temperature excursions (from June 2021-August 2021) prior to delivery; exposure to higher temperatures may have impacted product effectiveness. All lots received between 06/01/21-9/30/21.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • 2 of the 2 ancestors have a recall of any class.
  • 2 other devices also cite its predicate K023740.

How does its category compare?

All NZW devices

NZW Heparin, Vascular Access Flush: FDA decisions, review times, recalls and adverse event reports over 20 years. 2014, this device’s year, is highlighted.

FDA decisions per year · NZW

1in 2017

2007: 12009: 12010: 22014: 12017: 1
2007high 2 (2010) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NZW

Too few NZW 510(k)s in any year since 2007 to give a median.

Recalls per year · NZW

1in 2014

2008: 222010: 32012: 12014: 1
2007high 22 (2008) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · NZW

11in 2025

2007: 212008: 2912009: 1222010: 1942011: 332012: 92013: 152014: 82015: 52017: 32018: 192019: 192020: 32021: 102022: 142023: 92024: 102025: 11
2007high 291 (2008) · low 0 (2016)2025

MAUDE reports naming product code NZW, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—021
20080—22291
20091—0122
20102—3194
20110—033
20120—19
20130—015
20141—18
20150—05
20160—00
20171—03
20180—019
20190—019
20200—03
20210—010
20220—014
20230—09
20240—010
20250—011
20260—0—

What is it indicated for?

Flushing of IV catheters and IV tubing only. Solution is intended for maintenance of patency of intravenous injection devices. Prior to and after administration of intermittent medication, entirely flush the intravenous injection device (catheter and or tubing) with Heparin Lock Solution, USP. Use in accordance with any warnings or precautions appropriate to medication being administered. This device is not to be used for anticoagulant therapy. Heparin…

Read the full statement (192 words)

Flushing of IV catheters and IV tubing only. Solution is intended for maintenance of patency of intravenous injection devices. Prior to and after administration of intermittent medication, entirely flush the intravenous injection device (catheter and or tubing) with Heparin Lock Solution, USP. Use in accordance with any warnings or precautions appropriate to medication being administered. This device is not to be used for anticoagulant therapy.

Heparin Lock Flush, USP is supplied as:

• 3 USP Units per 3 mL (1 USP unit per mL); 3 mL volume in a 10 mL syringe

• 6 USP Units per 3 mL (2 USP unit per mL); 3 mL volume in a 10 mL syringe

• 30 USP Units per 3 mL (10 USP unit per mL); 3 mL volume in a 10 mL syringe

• 50 USP Units per 5 mL (10 USP unit per mL); 5 mL volume in a 10 mL syringe

• 300 USP Units per 3 mL (100 USP unit per mL); 3 mL volume in a 10 mL syringe

• 500 USP Units per 5 mL (100 USP unit per mL); 5 mL volume in a 10 mL syringe

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K133446: Heparin Lock / Flush Syringes.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K133446

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026